A serial MRI study following optic nerve mean area in acute optic neuritis.

This study assessed optic nerve mean area on serial MRI in a cohort of patients with a first episode of acute unilateral optic neuritis to assess the effects of a single acute inflammatory demyelinating lesion. Twenty-nine patients with a median delay from onset of visual symptoms of 13 days (range 7-24 days) were recruited. After a clinical examination and visual evoked potential (VEP) measurement, each patient had their optic nerves imaged with a coronal fat-saturated short echo fast fluid-attenuated inversion recovery sequence. Twenty-one patients had serial examinations after 2, 4, 8, 12, 26 and 52 weeks. In addition, 32 control subjects had their optic nerves imaged up to three times. The mean cross-sectional area of the intra-orbital portion of each optic nerve was calculated by a blinded observer using a computer-assisted contouring technique. At baseline, the mean area of diseased optic nerves was 16.1 mm2 compared with 13.4 mm2 for healthy contralateral optic nerves (20.1% higher, P < 0.0001) and 13.6 mm2 for controls (18.4% higher, P = 0.0003). The diseased optic nerve mean area declined over time, from initial swelling to later atrophy. The mean decline at 52 weeks was -0.0018 mm2/day (95% confidence interval -0.0038 to -0.00051). At 52 weeks, the mean area of diseased optic nerves was 11.3 mm2 compared with 12.8 mm2 for healthy contralateral optic nerves (11.7% lower, P = 0.032) and 13.1 mm2 for controls (13.7% lower, P = 0.008). The 52 week diseased optic nerve mean area was not significantly affected by the baseline mean area. There was an association between baseline optic nerve mean area and logMAR visual acuity (rS = 0.46, P = 0.012) and visual field mean deviation (rS = -0.55, P = 0.002), but there was no evidence of an association between 1 year mean area and visual outcome. There was no evidence of association between baseline, rates of decline or 1 year diseased optic nerve mean areas and any of the baseline, 1 year or time-averaged VEP variables. The present study shows a consistent pattern of changes associated with individual inflammatory demyelinating lesions in the optic nerve. Acutely, there was swelling, consistent with the presence of acute inflammation, which was related to visual impairment. Over the longer term, there was loss of tissue. The lack of association between 1 year optic nerve mean area and visual outcome may reflect a mild loss of tissue, redundancy or remodelling of function.

[1]  W. I. McDonald,et al.  Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis , 1996, Neurology.

[2]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[3]  H. Quigley,et al.  Visual acuity in optic atrophy: a quantitative clinicopathological analysis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  Massimo Filippi,et al.  Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. , 2002, Archives of neurology.

[5]  G. Barker,et al.  Technical issues for the study of the optic nerve with MRI , 2000, Journal of the Neurological Sciences.

[6]  H. Goldstein Multilevel Statistical Models , 2006 .

[7]  G J Barker,et al.  Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[8]  G. Barker,et al.  Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI , 1996, Neuroradiology.

[9]  N. Newman,et al.  Walsh and Hoyt's Clinical Neuro-Ophthalmology, 4th ed , 1982 .

[10]  J Carpenter,et al.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. , 2000, Statistics in medicine.

[11]  B E Kendall,et al.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. , 1991, Brain : a journal of neurology.

[12]  F. Lublin,et al.  Effect of relapses on development of residual deficit in multiple sclerosis , 2003, Neurology.

[13]  N. Newman,et al.  Walsh and Hoyt's Clinical Neuro Ophthalmology , 1982 .

[14]  G. W. Snedecor Statistical Methods , 1964 .

[15]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[16]  Stephen J. Jones,et al.  Serial magnetization transfer imaging in acute optic neuritis. , 2003, Brain : a journal of neurology.

[17]  Moses Rodriguez,et al.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. , 2000, Brain : a journal of neurology.

[18]  D. Quint,et al.  MRI of optic nerve enlargement in optic neuritis , 1997, Neurology.

[19]  L. Levin,et al.  Optic neuritis and multiple sclerosis. , 2003, Archives of ophthalmology.

[20]  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. , 1991, Archives of ophthalmology.

[21]  J. Corbett Experience of the optic neuritis treatment trial , 2004, Current Neurology and Neuroscience Reports.

[22]  W. I. McDonald,et al.  Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis , 1998, Neurology.

[23]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[24]  W. Mcdonald,et al.  Delayed visual evoked response in optic neuritis. , 1972, Lancet.

[25]  L. Candelise,et al.  Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. , 2000, Journal of neurology.

[26]  Robin Franklin,et al.  Axon loss in multiple sclerosis , 1998, The Lancet.

[27]  S J Hickman,et al.  Continuing optic nerve atrophy following optic neuritis: a serial MRI study , 2002, Multiple sclerosis.

[28]  W. Mcdonald,et al.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  F. Ferris,et al.  New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.

[30]  Stephen J. Jones,et al.  Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. , 2001, Brain : a journal of neurology.

[31]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[32]  G. T. Plant,et al.  Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence , 2001, Neuroradiology.

[33]  M. Kupersmith,et al.  Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. , 2002, Brain : a journal of neurology.

[34]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[35]  G. Plant,et al.  Corticosteroids do not prevent optic nerve atrophy following optic neuritis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[36]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[37]  B E Kendall,et al.  Optic neuritis: swelling and atrophy. , 1996, Electroencephalography and clinical neurophysiology. Supplement.

[38]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.